lansoprazole has been researched along with Esophageal Diseases in 8 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole has undergone extensive clinical evaluation for the treatment of acid-peptic diseases." | 2.40 | Safety profile of Lansoprazole: the US clinical trial experience. ( Freston, JW; Haber, M; Heller, CA; Jennings, D; Rose, PA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oe, S | 1 |
| Watanabe, T | 1 |
| Kume, K | 1 |
| Shibata, M | 1 |
| Hiura, M | 1 |
| Yoshikawa, I | 1 |
| Harada, M | 1 |
| Choi, KE | 1 |
| Kim, MJ | 1 |
| Lee, JH | 2 |
| Lee, JS | 1 |
| Choe, YH | 1 |
| Silvers, WS | 1 |
| Levine, JS | 1 |
| Poole, JA | 1 |
| Naar, E | 1 |
| Weber, RW | 1 |
| Cooper, BT | 1 |
| Chapman, W | 1 |
| Neumann, CS | 1 |
| Gearty, JC | 1 |
| Kobayashi, S | 1 |
| Kawabe, N | 1 |
| Miyata, F | 1 |
| Ito, H | 1 |
| Kazumiya, H | 1 |
| Murase, K | 1 |
| Kurokawa, S | 1 |
| Fujishima, K | 1 |
| Freston, JW | 1 |
| Rose, PA | 1 |
| Heller, CA | 1 |
| Haber, M | 1 |
| Jennings, D | 1 |
| Cuddihy, PJ | 1 |
| Maheshwar, A | 1 |
| Griffith, H | 1 |
| Miehsler, W | 1 |
| Püspök, A | 1 |
| Oberhuber, T | 1 |
| Vogelsang, H | 1 |
1 review available for lansoprazole and Esophageal Diseases
| Article | Year |
|---|---|
Safety profile of Lansoprazole: the US clinical trial experience.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clinical Trials as Topic; Esophageal Dis | 1999 |
7 other studies available for lansoprazole and Esophageal Diseases
| Article | Year |
|---|---|
A case of idiopathic gastroesophageal submucosal hematoma and its disappearance observed by endoscopy.
Topics: Aged; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Esophageal Diseases; Esophagogastric Junction; | 2014 |
Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Child; Child, Preschool; Cohort Studies; Endosc | 2012 |
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Androstadienes; Anti-Allergic Agents; Cough; Endoscopy, Gas | 2006 |
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Eso | 2006 |
[A case of Behcet's syndrome associated with esophageal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Behcet | 1998 |
Symptomatic heterotopic gastric mucosa in the upper oesophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Choristoma; Cimetidine; Esophageal Disea | 1998 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |